|
Arix Bioscience PLC said on Monday its net asset value at January 31 was 180 pence, down from 182p at the end of October, 2022. London-based Arix added its total portfolio NAV at January 31 was £232.9 million, down from £235.4 as of October 31, 2022. Arix Bioscience is a venture capital company focused on investing in biotechnology companies. Shares in firm closed up 2.80% at 110p in London on Tuesday. By Jeremy Cutler, Alliance News reporter. . Copyright 2023 Alliance News Ltd. All Rights Reserved.
|
